Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 8.05 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.31 | -3.71% | 8.05 | 8.47 | 7.8151 | 8.37 | 8.36 | 00:00:08 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 7.85 | 8.07 | 0.22 | 2.73% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,561 | 401,319 | $ 8.14 | $ 3,266,149 | 940,570 | 2.75 - 16.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:11:48 | 25 | $ 8.00 | USD |
Zynerba Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 186.74M | 23.20M | $ -39.91M | -2.67 | - | 21.06M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 7.00 | 9.20% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.55 | 8.48 | 7.36 | 7.9088 | 453k | 0.5 | 6.62% |
| 1 Month | 8.34 | 8.48 | 6.83 | 7.7857 | 662k | -0.29 | -3.48% |
| 3 Months | 11.02 | 12.51 | 6.83 | 9.7634 | 842k | -2.97 | -26.95% |
| 6 Months | 8.12 | 16.47 | 6.83 | 11.9790 | 2M | -0.07 | -0.86% |
| 1 Year | 7.4 | 16.47 | 2.75 | 9.7558 | 1M | 0.65 | 8.78% |
| 3 Years | 11.55 | 25.95 | 2.75 | 10.7393 | 767k | -3.5 | -30.30% |
| 5 Years | 18 | 43 | 2.75 | 10.9357 | 603k | -9.95 | -55.28% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates. |
